Influenza Research and Development
Conference - San Francisco, CA, USA
GTC is proud to present its inaugural Influenza Research and Development conference, to be held in San Francisco, CA on July 9-10, 2012. This conference will bring together the leaders in the field from industry, academia, and the government from the US and other countries to discuss all aspects of influenza. This conference will cover important aspects of basic research in influenza including correlates of protection, the role of T-cells in influenza, immunity to influenza, antibodies, adjuvants and vaccination. In addition, there will be discussions of the current threat of the H5N1 virus and updates on the universal influenza vaccine. We should never forget the role of epidemiologists and of scientists around the globe following the identification and progressions of new strains. These and other topics will be covered by key academic and industrial researchers and by the leaders of the industry from technology transfer, manufacturing, regulatory and clinical trials, all vital elements for a successful influenza vaccine product. Additionally, government representatives from BARDA, FDA, DOD and the USAID as well as NGO representatives will discuss regulatory and government policies for vaccinations in conjunction with our 10th Vaccines Research and Development: All Things Considered Conference.
(Photo courtesy of http://www.gtcbio.com/component/conference/?file=home&cn=Influenza+Research+and+Development&cid=88)
Jul 09, 2012 to Jul 10, 2012
San Francisco, CA, USA
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows
